used a chemically-synthesized microRNA (miR-143) to inhibit glycolysis through the downregulation of hexokinase 2 (HK2), which resulted in reduction of tumor growth and corresponding decreases in FDG uptake by PET/CT (74). This evidence concerns the gene HK2 and neoplasm.